scholarly article | Q13442814 |
P356 | DOI | 10.1002/PROS.21090 |
P698 | PubMed publication ID | 19938014 |
P50 | author | Karen Alt | Q61013891 |
Philipp Wolf | Q61089862 | ||
P2093 | author name string | Patrick Bühler | |
Ursula Elsässer-Beile | |||
Ulrich Wetterauer | |||
Nikolaus Freudenberg | |||
Wolfgang Schultze-Seemann | |||
P2860 | cites work | Biochemical characterization and mapping of the 7E11-C5.3 epitope of the prostate-specific membrane antigen | Q44962359 |
P433 | issue | 5 | |
P921 | main subject | antibody | Q79460 |
P304 | page(s) | 562-569 | |
P577 | publication date | 2010-04-01 | |
P1433 | published in | The Prostate | Q7758608 |
P1476 | title | Three conformational antibodies specific for different PSMA epitopes are promising diagnostic and therapeutic tools for prostate cancer | |
P478 | volume | 70 |
Q33792596 | 'Image and treat': an individualized approach to urological tumors |
Q34458153 | 64Cu antibody-targeting of the T-cell receptor and subsequent internalization enables in vivo tracking of lymphocytes by PET. |
Q35446801 | A targeted low molecular weight near-infrared fluorescent probe for prostate cancer |
Q36279293 | Anti-tumor effects of a recombinant anti-prostate specific membrane antigen immunotoxin against prostate cancer cells |
Q89779969 | Comparison of Prostate-Specific Membrane Antigen Expression Levels in Human Salivary Glands to Non-Human Primates and Rodents |
Q37591940 | Functional prostate-specific membrane antigen is enriched in exosomes from prostate cancer cells |
Q33827632 | GCPII imaging and cancer |
Q37972920 | Glutamate carboxypeptidase II in diagnosis and treatment of neurologic disorders and prostate cancer |
Q36125199 | Imaging prostate cancer: an update on positron emission tomography and magnetic resonance imaging |
Q38896408 | In vitro and in vivo effects of a recombinant anti-PSMA immunotoxin in combination with docetaxel against prostate cancer. |
Q39198527 | Metal-Based PSMA Radioligands |
Q24634139 | Multifunctional iron platinum stealth immunomicelles: targeted detection of human prostate cancer cells using both fluorescence and magnetic resonance imaging |
Q34420372 | Neutrophil granulocytes recruited upon translocation of intestinal bacteria enhance graft-versus-host disease via tissue damage. |
Q28544848 | PSMA ligand conjugated PCL-PEG polymeric micelles targeted to prostate cancer cells |
Q41273648 | PSMA redirects cell survival signaling from the MAPK to the PI3K-AKT pathways to promote the progression of prostate cancer |
Q98165142 | PSMA-Directed CAR T Cells Combined with Low-Dose Docetaxel Treatment Induce Tumor Regression in a Prostate Cancer Xenograft Model |
Q36962425 | Prostate extracellular vesicles in patient plasma as a liquid biopsy platform for prostate cancer using nanoscale flow cytometry |
Q36135685 | Prostate specific membrane antigen- a target for imaging and therapy with radionuclides. |
Q36160805 | Prostate-cancer-targeted N-(2-hydroxypropyl)methacrylamide copolymer/docetaxel conjugates |
Q41192097 | Prostate-specific membrane antigen PET imaging and immunohistochemistry in adenoid cystic carcinoma-a preliminary analysis |
Q87193518 | Prostate-specific membrane antigen as a marker of pancreatic cancer cells |
Q38015617 | Prostate-specific membrane antigen-based imaging |
Q38955091 | Splice variant transcripts of the anterior gradient 2 gene as a marker of prostate cancer |
Q38167022 | Strategies for imaging androgen receptor signaling pathway in prostate cancer: implications for hormonal manipulation and radiation treatment |
Q47731005 | Targeting PSMA by radioligands in non-prostate disease-current status and future perspectives |
Search more.